Perspective Therapeutics Inc. Share Price Today: Live Updates & Key Insights
Perspective Therapeutics Inc. share price today is $4.45, up -3.26%. The stock opened at $4.6 against the previous close of $4.6, with an intraday high of $4.77 and low of $4.405.
Perspective Therapeutics Inc. Share Price Chart
Perspective Therapeutics Inc.
Perspective Therapeutics Inc. Share Price Performance
Perspective Therapeutics Inc. Institutional Holdings
Perspective Therapeutics Inc. Market Status
Perspective Therapeutics Inc. Fundamentals
Market Cap 507.00 M
PB Ratio 2.4489
PE Ratio 0.0
Enterprise Value 365.52 M
Total Assets 266.97 M
Volume 7432675
Perspective Therapeutics Inc. Company Financials
About Perspective Therapeutics Inc. & investment objective
Company Information Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; and PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha. The company also develops Pluvicto, a betaemitting radioligand therapy to treat progressive prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.
Organisation Medical Devices
Employees 163
Industry Medical Devices
CEO Mr. Johan M. Spoor
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Perspective Therapeutics Inc. FAQs
What is the share price of Perspective Therapeutics Inc. today?
The current share price of Perspective Therapeutics Inc. is $4.45.
Can I buy Perspective Therapeutics Inc. shares in India?
Yes, Indian investors can buy Perspective Therapeutics Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Perspective Therapeutics Inc. shares in India?
You can easily invest in Perspective Therapeutics Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Perspective Therapeutics Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Perspective Therapeutics Inc..
Can I buy fractional shares of Perspective Therapeutics Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Perspective Therapeutics Inc.?
Perspective Therapeutics Inc. has a market cap of $507.00 M.
In which sector does Perspective Therapeutics Inc. belong?
Perspective Therapeutics Inc. operates in the Medical Devices sector.
What documents are required to invest in Perspective Therapeutics Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Perspective Therapeutics Inc.?
The PE ratio of Perspective Therapeutics Inc. is N/A and the PB ratio is 2.45.